Lubrizol Showcases Medical Device Manufacturing at WHX Dubai

Lubrizol will showcase its medical device manufacturing innovations at World Health Expo (WHX) Dubai from February 9–12, 2026, highlighting its commitment to advancing healthcare solutions through global manufacturing.

The company is expanding its presence in India with new contract manufacturing capacity with a state-of-the-art medical manufacturing plant at Chennai, Tamil Nadu, which will be operational during mid-2026.

The facility will specialise in the manufacture of highly accurate medical tubing to neurovascular and cardiovascular uses such as balloon catheters and parts used in minimally invasive surgery.

Also Read: Navigating the New Era of Nitrosamine Compliance

The Chennai plant will take advantage of the experience of the Lubrizol company in the area of medical-grade thermoplastic polyurethane (TPU) and other biocompatible engineered polymers. Its services will involve single and multi-lumen, high-precision, extrusion of TPU, Nylon, Pebax 2, and other thermoplastics, as well as tri-layered and balloon tubing and complicated braiding. The applications associated with these solutions are diverse and are used in electro stimulation, cardiovascular, and neurovascular therapies.

“Our investments in India reflect a long-term commitment to local manufacturing, R&D and technical excellence,” said Mittal Shah, Business Head, Lubrizol. “By expanding high-performance, biocompatible manufacturing capabilities, we are enabling customers to accelerate medical device development for India and global markets.”

Lubrizol representatives will be at WHX Dubai to meet visitors at the stand, where they can discuss design, development, and manufacturing solutions of the next generation medical equipment. The increasing presence in India influences the commitment of the company to promoting innovation in the production of medical devices at an international level.